Biomex
Provider of human biospecimens, biobanking and laboratory services for diagnostics, life sciences and IVD validation. Offers large commercial inventories of clinical samples and FFPE tissue, prospective collection via clinical networks, assay validation panels and study execution support including PCR testing and regulatory validation services.
Industries
Nr. of Employees
medium (51-250)
Patents
Amphoteric fluorescent substance capable of being attached to biomaterials
US-12545641-B2
View DetailsPeptide ligand targeting carbonic anhydrase IX, peptide construct comprising same, and uses thereof
US-12486304-B2
View Details
Amphoteric fluorescent substance capable of being attached to biomaterials
US-12545641-B2
View DetailsPeptide ligand targeting carbonic anhydrase IX, peptide construct comprising same, and uses thereof
US-12486304-B2
View DetailsProducts
SARS-CoV-2 immunity seroconversion panels
Post-vaccination seroconversion panels composed of serial donations from vaccinated donors to support assay detection of vaccine-induced antibodies and quantify antibody concentrations.
HCV and syphilis validation panels
Validation and seroconversion sample panels for hepatitis C and syphilis to determine analytical parameters such as LOD and LOQ during assay validation.
Annotated FFPE tissue inventory
Commercial access to a large inventory of FFPE tissue blocks for research and molecular analysis, including tumor tissue collections.
HCV Ag
The Biomex GmbH HCV Ag Only Seroconversion Panel consists of 5 members with each member containing 1.0 mL of human sodium citrate plasma, illustrating the onset of the Hepatitis C virus (Genotype 2b) core antigen from one individual over a period of 21 days.
HCV Ag Validation Panel High
The Biomex GmbH HCV Ag Validation Panel High consists of 20 members spanning the upper range of quantification to enable developers to challenge their HCV Ag assays.
HCV Ag Linearity Panel Max
The Biomex GmbH HCV Antigen Linearity Panel Max consists of 100 members spanning a wide range of quantification, enabling developers to challenge their HCV Ag assays and estimate limits of detection and quantification.
SARS-CoV-2 immunity seroconversion panels
Post-vaccination seroconversion panels composed of serial donations from vaccinated donors to support assay detection of vaccine-induced antibodies and quantify antibody concentrations.
HCV and syphilis validation panels
Validation and seroconversion sample panels for hepatitis C and syphilis to determine analytical parameters such as LOD and LOQ during assay validation.
Annotated FFPE tissue inventory
Commercial access to a large inventory of FFPE tissue blocks for research and molecular analysis, including tumor tissue collections.
HCV Ag
The Biomex GmbH HCV Ag Only Seroconversion Panel consists of 5 members with each member containing 1.0 mL of human sodium citrate plasma, illustrating the onset of the Hepatitis C virus (Genotype 2b) core antigen from one individual over a period of 21 days.
HCV Ag Validation Panel High
The Biomex GmbH HCV Ag Validation Panel High consists of 20 members spanning the upper range of quantification to enable developers to challenge their HCV Ag assays.
HCV Ag Linearity Panel Max
The Biomex GmbH HCV Antigen Linearity Panel Max consists of 100 members spanning a wide range of quantification, enabling developers to challenge their HCV Ag assays and estimate limits of detection and quantification.
Services
Commercial access to annotated human biospecimens via an online sampleshop; filtering and search of available patient samples and ordering support.
Custom prospective collections organized via a network of clinics and practices according to customer specifications.
End-to-end validation studies for in-vitro diagnostics including study design, ethics, sample management, laboratory testing, analysis and reporting to support regulatory pathways.
Creation and distribution of seroconversion and validation panels for infectious disease assay development and verification.
Molecular testing capability provided via a BSL-2 laboratory with high daily throughput.
Commercial access to annotated human biospecimens via an online sampleshop; filtering and search of available patient samples and ordering support.
Custom prospective collections organized via a network of clinics and practices according to customer specifications.
End-to-end validation studies for in-vitro diagnostics including study design, ethics, sample management, laboratory testing, analysis and reporting to support regulatory pathways.
Creation and distribution of seroconversion and validation panels for infectious disease assay development and verification.
Molecular testing capability provided via a BSL-2 laboratory with high daily throughput.
Expertise Areas
- Biospecimen sourcing and biobanking
- IVD validation and clinical study execution
- Assay validation panel development
- Molecular diagnostics (PCR/serology) testing
Key Technologies
- Biobanking and sample annotation
- Seroconversion/validation panels
- PCR (molecular diagnostics)
- CLIA and ELISA testing
News & Updates
Completed the 130th SARS-CoV-2 antigen assay validation and expanded laboratory capacity and personnel to meet demand.
Set up a fully functional biosafety level 2 laboratory capable of processing up to 3,000 PCR tests per day within a short timeframe.
Acquired Atreide Biosamples to strengthen tumor tissue procurement capabilities and expand FFPE block inventory.
Company donation to support acquisition of a mass spectrometer for pediatric cancer analysis and therapy research.
Completed the 130th SARS-CoV-2 antigen assay validation and expanded laboratory capacity and personnel to meet demand.
Set up a fully functional biosafety level 2 laboratory capable of processing up to 3,000 PCR tests per day within a short timeframe.
Acquired Atreide Biosamples to strengthen tumor tissue procurement capabilities and expand FFPE block inventory.
Company donation to support acquisition of a mass spectrometer for pediatric cancer analysis and therapy research.